186 related articles for article (PubMed ID: 24721231)
1. Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients.
Sahasrabhojane P; Galloway-Peña J; Velazquez L; Saldaña M; Horstmann N; Tarrand J; Shelburne SA
Int J Antimicrob Agents; 2014 Jun; 43(6):558-62. PubMed ID: 24721231
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae.
Ip M; Chau SS; Chi F; Tang J; Chan PK
Antimicrob Agents Chemother; 2007 Aug; 51(8):2690-700. PubMed ID: 17548487
[TBL] [Abstract][Full Text] [Related]
3. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman MA; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jun; 55(2):119-27. PubMed ID: 16530373
[TBL] [Abstract][Full Text] [Related]
4. In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis.
Janoir C; Podglajen I; Kitzis MD; Poyart C; Gutmann L
J Infect Dis; 1999 Aug; 180(2):555-8. PubMed ID: 10395882
[TBL] [Abstract][Full Text] [Related]
5. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
Balsalobre L; de la Campa AG
Antimicrob Agents Chemother; 2008 Mar; 52(3):822-30. PubMed ID: 18160515
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
[TBL] [Abstract][Full Text] [Related]
7. Emergence of fluoroquinolone-resistant Stenotrophomonas maltophilia in blood isolates causing bacteremia: molecular epidemiology and microbiologic characteristics.
Cha MK; Kang CI; Kim SH; Cho SY; Ha YE; Chung DR; Peck KR; Song JH
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):210-2. PubMed ID: 27117514
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of garenoxacin (BMS-284756) against Streptococcus pneumoniae, viridans group streptococci, and Enterococcus faecalis compared to those of six other quinolones.
Grohs P; Houssaye S; Aubert A; Gutmann L; Varon E
Antimicrob Agents Chemother; 2003 Nov; 47(11):3542-7. PubMed ID: 14576115
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
10. Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010-2012.
Wajima T; Morozumi M; Chiba N; Shouji M; Iwata S; Sakata H; Ubukata K
Int J Antimicrob Agents; 2013 Nov; 42(5):447-9. PubMed ID: 23988719
[TBL] [Abstract][Full Text] [Related]
11. Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.
Uchida Y; Mochimaru T; Morokuma Y; Kiyosuke M; Fujise M; Eto F; Harada Y; Kadowaki M; Shimono N; Kang D
Int J Antimicrob Agents; 2010 Apr; 35(4):387-91. PubMed ID: 20138480
[TBL] [Abstract][Full Text] [Related]
12. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of fluoroquinolone-nonsusceptible Streptococcus pyogenes emm12 in Taiwan.
Lin JN; Chang LL; Lai CH; Huang YH; Chen WF; Yang CH; Hsu J; Lin HH; Chen YH
Diagn Microbiol Infect Dis; 2015 Oct; 83(2):187-92. PubMed ID: 26234479
[TBL] [Abstract][Full Text] [Related]
14. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.
Smeesters PR; Vergison A; Junior DC; Van Melderen L
Int J Antimicrob Agents; 2009 Jul; 34(1):44-9. PubMed ID: 19269141
[TBL] [Abstract][Full Text] [Related]
15. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
Beeton ML; Chalker VJ; Kotecha S; Spiller OB
J Antimicrob Chemother; 2009 Sep; 64(3):529-38. PubMed ID: 19567408
[TBL] [Abstract][Full Text] [Related]
16. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone resistance among Neisseria gonorrhoeae isolates from Shanghai, China: detection of quinolone resistance-determining region mutations.
Tiejun Z; Xiaoming Z; Jilun Z; Yinghu Z; Yanhua R; Yue C; Weiming G; Tao Z; Qingwu J
Indian J Med Res; 2009 Jun; 129(6):701-6. PubMed ID: 19692753
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and phylogenetic analysis of quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and parE gene loci in viridans group streptococci isolated from adult patients with cystic fibrosis.
Maeda Y; Murayama M; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Matsuda M; Rendall JC; Elborn JS; Moore JE
J Antimicrob Chemother; 2011 Mar; 66(3):476-86. PubMed ID: 21193474
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.
Adam HJ; Schurek KN; Nichol KA; Hoban CJ; Baudry TJ; Laing NM; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2007 Jan; 51(1):198-207. PubMed ID: 17088485
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
Orscheln RC; Johnson DR; Olson SM; Presti RM; Martin JM; Kaplan EL; Storch GA
J Infect Dis; 2005 Apr; 191(8):1272-9. PubMed ID: 15776373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
